This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 2042466 results found since Jan 2013.

Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Autologous Natural Killer Cell Therapy;   Device: Clinimacs Plus Sponsor:   Dr Cipto Mangunkusumo General Hospital Recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
Condition:   Advanced Non-small Cell Lung Cancer Intervention:   Drug: almonertinib Sponsor:   Qianfoshan Hospital Recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
Conditions:   Non-Small Cell Lung Cancer;   NSCLC;   EGFR/HER2 Exon 20 Insertion Mutation Intervention:   Drug: STX-721 Sponsor:   Scorpion Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Pancreatic, Colorectal and Non-Small Cell Lung Cancers With KRAS G12V Mutations
Conditions:   Metastatic Colorectal Adenocarcinoma;   Metastatic Lung Non-Small Cell Carcinoma;   Metastatic Pancreatic Adenocarcinoma;   Stage IV Colorectal Cancer AJCC v8;   Stage IV Lung Cancer AJCC v8;   Stage IV Pancreatic Cancer AJCC v8 Interventions:   Drug: Bendamustine;   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Procedure: Computed Tomography;   Drug: Cyclophosphamide;   Procedure: Echocardiography;   Drug: Fludarabine;   Procedure: Leukapheresis;   Procedure: Magnetic Resonance Imaging;   Procedure: M ultigated Acquisition Scan;   Procedure:...
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Condition:   Renal Cell Carcinoma Intervention:   Drug: HS-10516 Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Conditions:   Lymphoma, Non-Hodgkin;   Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Mantle-Cell;   Lymphoma, Follicular;   Lymphoma, B-Cell Intervention:   Drug: ALETA-001 Sponsors:   Cancer Research UK;   Aleta BioTherapeutics Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
Condition:   Esophageal Squamous Cell Carcinoma Interventions:   Drug: Carrelizumab;   Drug: Paclitaxel injection;   Drug: Cisplatin;   Radiation: Concurrent chemoradiotherapy Sponsor:   The First Affiliated Hospital with Nanjing Medical University Enrolling by invitation
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Condition:   Multiple Myeloma Interventions:   Biological: idecabtagene vicleucel;   Drug: Lenalidomide;   Drug: Fludarabine;   Drug: Cyclophosphamide Sponsor:   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer
Condition:   Non-small Cell Lung Cancer Metastatic Intervention:   Sponsors:   Ari Raphael;   Bar-Ilan University, Israel;   Merck Sharp & Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Establishment of a Primary Epididymal Cell Model From Epididymal Samples to Study CFTR Gene Regulation
Conditions:   Cystic Fibrosis;   Congenital Bilateral Absence of Vas Deferens;   Sterility, Male Intervention:   Procedure: Epididymal sample Sponsor:   University Hospital, Brest Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer
Condition:   Neoplasms Interventions:   Drug: GSK3901961;   Drug: Cyclophosphamide;   Drug: Fludarabine Sponsor:   GlaxoSmithKline Terminated
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma
Condition:   Relapsed or Refractory B-cell Lymphoma Intervention:   Biological: infusion of JY231 injection Sponsor:   Guangdong Second Provincial General Hospital Recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Borrelia B-cell Diagnostics
Conditions:   Lyme Disease;   Borrelia Infections Intervention:   Procedure: venous blood puncture Sponsors:   University Children's Hospital, Zurich;   Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Condition:   Large B-cell Lymphoma Interventions:   Drug: Prednisone;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Epcoritamab Sponsor:   M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody
Conditions:   Lung Cancer;   TKI Resistance;   EGFR Sensitive Mutation;   Anlotinib;   Pianzumab Interventions:   Drug: Anlotinib;   Drug: Penpulimab Sponsors:   Degan Lu;   Wu Jieping Medical Foundation Not yet recruiting
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials